The history of Viagra presents a complex picture for investors. While the initial launch generated substantial gains, the expiration of its patent opened the floodgates to generic versions, dramatically diminishing sales. This poses a unique challenge for drug manufacturers depending on related blockbuster offerings, suggesting that a careless inve

The story of Viagra, and its creator copyright, presents a complex case study for investors. At first a blockbuster drug, generating billions in sales , its exclusivity period created a deluge of generic competition , significantly eroding its dominance. While specific businesses may attempt to capitalize on related treatments , the current landsca